home · filing · 0001437749-23-026257
8-K filed September 19, 2023, 7:59 PM ET
ticker CLNN
CIK 0001822791
leadership
confidence high
sentiment neutral
materiality 0.30
Clene appoints Prof. Kiernan and Dr. Desai to Board; Dr. Stevens retires
Clene Inc.
Appointed Prof. Matthew Kiernan (neurology chair, University of Sydney) and Dr. Arjun Desai (INSIGHTEC exec) as Class II directors.
Each received 45,000 common stock options at $0.54 exercise price, vesting monthly over 36 months.
Director John H. Stevens retired immediately, not due to any disagreement; he served since 2015.
Jonathon T. Gay joined Audit Committee; Dr. Desai joined Compensation Committee.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
John H. Stevens
Class II Director
Filed September 19, 2023, 7:59 PM ET
John H. Stevens, M.D., a Class II director of the Company, informed the Board of his decision to retire from the Board and all committees
Appointed
Matthew Kiernan
Class II Director
Effective 2023-09-18
Filed September 19, 2023, 7:59 PM ET
appointed Professor Matthew Kiernan AM, Ph.D., DSc, and Arjun (JJ) Desai, M.D., as members of the Board, effective September 18, 2023.
Appointed
Arjun Desai
Class II Director
Effective 2023-09-18
Filed September 19, 2023, 7:59 PM ET
appointed Professor Matthew Kiernan AM, Ph.D., DSc, and Arjun (JJ) Desai, M.D., as members of the Board, effective September 18, 2023.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
John H. Stevens retired as Class II Director at Clene Inc..
Action retired
Role Class II Director
Exact text from the filing
John H. Stevens, M.D., a Class II director of the Company, informed the Board of his decision to retire from the Board and all committees
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Matthew Kiernan was appointed as Class II Director at Clene Inc..
Action appointed
Role Class II Director
Exact text from the filing
appointed Professor Matthew Kiernan AM, Ph.D., DSc, and Arjun (JJ) Desai, M.D., as members of the Board, effective September 18, 2023.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Arjun Desai was appointed as Class II Director at Clene Inc..
Action appointed
Role Class II Director
Exact text from the filing
appointed Professor Matthew Kiernan AM, Ph.D., DSc, and Arjun (JJ) Desai, M.D., as members of the Board, effective September 18, 2023.
View on SEC.gov
Source: SEC EDGAR
accession 0001437749-23-026257
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.